U.S. Medicare sets outpatient rate for Yescarta reimbursement

(Reuters) – Medicare, the U.S. government healthcare program for the elderly and disabled, will pay hospitals close to its standard mark-up rate for administering cell therapy Yescarta for cancer outpatients, who will have a co-payment of nearly $80,000, according to the Centers for Medicare & Medicaid Services (CMS).


Source: Reuters Medical News

JPM, Amazon, Berkshire will use data to improve healthcare

NEW YORK (Reuters) – JPMorgan Chase & Co, Amazon.com Inc., and Berkshire Hathaway will focus on the biggest health issues threatening the U.S. economy in their new joint venture, including aligning healthcare payments with employee health and addressing chronic diseases, CEO Jamie Dimon said in his annual letter to shareholders. [nL2N1RI0U7]


Source: Reuters Medical News